Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Blankenstein, Thomas Prof. Dr. (2) Daniel, Peter Prof. Dr. (1) Leisegang, Matthias Dr. (5) Lusatis, Simone (1) Mathas, Stephan Dr. (7) Selbach, Matthias Prof. Dr. (5) Uckert, Wolfgang Prof. Dr. (11) Wollert-Wulf, Brigitte (2) (-) Janz, Martin Dr. (5) (-) Kieback, Elisa Dr. (3) (-) Biologie maligner Lymphome (5) Experimentelle Genetik von Herz- Kreislauferkrankungen (1) (-) Molekulare Zellbiologie und Gentherapie (4) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (5) 2007 (2) 2008 (4) 2009 (3) (-) 2010 (3) 2011 (4) 2012 (2) 2013 (2) 2014 (4) 2015 (3) 2016 (2) 2017 (5) 2018 (2) 2020 (4) 8 Ergebnisse: Active Filter: Janz, Martin Dr.Kieback, Elisa Dr.Biologie maligner LymphomeMolekulare Zellbiologie und Gentherapie20062010 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Mai 2010 in Nat Med Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy G.M. Bendle C. Linnemann A.I. Hooijkaas L. Bies M.A. de Witte A. Jorritsma A.D.M. Kaiser N. Pouw R. Debets E. Kieback W. Uckert J.Y. Song J.B.A.G. Haanen T.N.M. Schumacher 01. Mai 2010 in Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas 01. Mai 2010 in Expert Opin Biol Ther Enhanced T cell receptor gene therapy for cancer E. Kieback W. Uckert 15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 05. Februar 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller 01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Mai 2010 in Nat Med Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy G.M. Bendle C. Linnemann A.I. Hooijkaas L. Bies M.A. de Witte A. Jorritsma A.D.M. Kaiser N. Pouw R. Debets E. Kieback W. Uckert J.Y. Song J.B.A.G. Haanen T.N.M. Schumacher
01. Mai 2010 in Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas
01. Mai 2010 in Expert Opin Biol Ther Enhanced T cell receptor gene therapy for cancer E. Kieback W. Uckert
15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
05. Februar 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller
01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
